Tonix Pharmaceuticals Holding Corp. announced that the European Patent Office issued a patent to the company for magnesium-containing oxytocin formulations and methods of use, providing market exclusivity until 2036.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.